Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Transgenomic, Inc. (PRPO) had Receiveable Turnover of 11.68 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$15.20M |
|
$-5.85M |
|
$9.18M |
|
$6.02M |
|
$22.82M |
|
$-7.62M |
|
$1.77M |
|
$-5.85M |
|
$-5.85M |
|
$-5.85M |
|
$-5.85M |
|
$-5.85M |
|
$-5.85M |
|
$-7.62M |
|
$-6.10M |
|
1.30M |
|
1.30M |
|
$-4.51 |
|
$-4.51 |
|
| Balance Sheet Financials | |
$3.68M |
|
$0.74M |
|
$14.42M |
|
$18.10M |
|
$3.14M |
|
$0.12M |
|
$0.53M |
|
$3.67M |
|
$14.43M |
|
$1.61M |
|
$14.43M |
|
1.42M |
|
| Cash Flow Statement Financials | |
$-3.56M |
|
$-0.13M |
|
$1.74M |
|
$3.44M |
|
$1.50M |
|
$-1.94M |
|
$1.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.17 |
|
-- |
|
-- |
|
0.01 |
|
0.03 |
|
39.60% |
|
-50.14% |
|
-50.14% |
|
-40.14% |
|
-38.51% |
|
-38.51% |
|
$-3.69M |
|
-- |
|
-- |
|
-- |
|
0.84 |
|
23.90 |
|
|
Receiveable Turnover |
11.68 |
31.25 |
|
-40.56% |
|
-363.31% |
|
-32.34% |
|
-40.22% |
|
$10.16 |
|
$-2.84 |
|
$-2.74 |
|